ONE-WAYOngoing theme · still written in the latest filings

Early Development and Launch of High-Value-Added Generic Pharmaceuticals

An initiative to expand the business through the early launch of high-value-added generic pharmaceuticals, advancing their development ahead of competitors and seeking marketing approval.

Companies6How many companies write about this.

Threads6One company can carry more than one thread here.

PeriodFY2022-Q1 →Still being written about.

Directionhelps6 helps · 0 hurts · 0 flat